Imprimis Pharmaceuticals Prices 1.84M Share Offering at $5.25/Share
Posted on February 07, 2013 at 20:34 PM EST
Imprimis Pharmaceuticals (NASDAQ: IMMY ), today announced the pricing of an underwritten public offering of 1,840,000 shares of its common stock at a price to the public of $5.25 per share, for gross proceeds of approximately $9.66 million. The net proceeds from the offering, after deducting underwriting discounts and